Is ticagrelor a CYP inhibitor?

Because ticagrelor is an inhibitor of CYP3A4 that accounts for about 15–30% of the total CYP enzyme in humans, the co-administration potentially affects efficacy and safety by altering tadalafil exposure [24].

How is ticagrelor metabolized?

Unlike remaining oral P2Y12 receptor inhibitors ticagrelor does not require metabolic activation to exert its antiplatelet action. Still, ticagrelor is extensively metabolized by hepatic CYP3A enzymes, and AR-C124910XX is its only active metabolite.

Where is Brilinta metabolized?

Ticagrelor is not a prodrug and does not require metabolic activation to inhibit the P2Y12 receptor; however, it is converted in the liver into an active metabolite, which is approximately equipotent (James 2009).

Does ticagrelor need hepatic activation?

Ticagrelor, unlike clopidogrel, does not require metabolic activation for its antiplatelet effects.

What is the mechanism of action of ticagrelor?

Mechanism of Action and Chemical Properties Ticagrelor is an orally administered direct-acting P2Y12-receptor antagonist. In vitro studies have demonstrated that ticagrelor binds reversibly and noncompetitively to the P2Y12 receptor at a site distinct from that of the endogenous agonist adenosine diphosphate (ADP).

Is ticagrelor a P2Y12?

Ticagrelor (AZD6140) is the first reversibly binding oral P2Y12 receptor antagonist that blocks ADP-induced platelet aggregation.

Is ticagrelor a prodrug?

Ticagrelor is not a prodrug and exhibits a more rapid onset of action than the thienopyridine prodrugs. In clinical trials conducted to date, ticagrelor was a potent inhibitor of ADP-induced platelet aggregation and demonstrated effects that were comparable to clopidogrel.

Does Brilinta affect the liver?

Ticagrelor is metabolized by the liver. The use of ticagrelor should be avoided in patients with severe hepatic impairment. Care should be taken in patients with moderate hepatic impairment and it is recommended to consider the risks and benefits of treatment due to the probable increase in exposure to ticagrelor.

Does BRILINTA affect the liver?

Is ticagrelor a P2Y12 inhibitor?

Clopidogrel, prasugrel, and ticagrelor are the most commonly used oral platelet P2Y12 inhibitors; the use of ticlopidine, the first available P2Y12 inhibitor, has been largely abandoned. Clopidogrel is the only oral P2Y12 inhibitor indicated for the treatment of patients with stable coronary artery disease.

What is P2Y12 inhibitor?

Aspirin is an antiplatelet drug that may be used. P2Y12 receptor blockers are another group of antiplatelet drugs. This group of drugs includes: clopidogrel, ticlopidine, ticagrelor, prasugrel, and cangrelor.

Is ticagrelor a thienopyridines?

Non-thienopyridine derivatives including ticagrelor, cangrelor and elinogrel do not require metabolic activation and lead to a reversible P2Y12 receptor inhibition in contrast to thienopyridines.

Which drugs are P2Y12 inhibitors?

Antiplatelet drugs – P2Y12 inhibitors

• Aspirin is an antiplatelet drug that may be used.
• P2Y12 receptor blockers are another group of antiplatelet drugs. This group of drugs includes: clopidogrel, ticlopidine, ticagrelor, prasugrel, and cangrelor.

What is the MOA of ticagrelor?

Ticagrelor binds to an area on the P2Y12 receptor distinct from the ADP binding site. BRILINTA reversibly binds to the ADP P2Y12 receptor and prevents ADP from binding. This prevents the signal transduction and platelet activation that can lead to pathologic thrombus formation.

Can I take CoQ10 with Brilinta?

Interactions between your drugs No interactions were found between Brilinta and CoQ10. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.

Can Brilinta cause kidney problems?

Although, ticagrelor can cause worsening of the kidney function, no dose adjustment is required in a patient with renal dysfunction [7].

Is Brilinta a P2Y12 inhibitor?

Brilinta and Plavix are part of a group of medications called antiplatelet agents, blood thinners, or P2Y12 inhibitors. Both drugs work as receptor antagonists, which means they block the P2Y12 receptor responsible for promoting platelets and blood clots.

What drugs should not be taken with Brilinta?

DRUGS. Avoid use of strong inhibitors of CYP3A (eg, ketoconazole, itraconazole, voriconazole, clarithromycin, nefazodone, ritonavir, saquinavir, nelfinavir, indinavir, atazanavir, and telithromycin). BRILINTA is metabolized by CYP3A4/5.

Does CoQ10 cause blood thinning?

CoQ10 might make blood-thinning drugs, such as warfarin (Jantoven), less effective. This could increase the risk of a blood clot.

Can Brilinta cause a brain bleed?

The PEGASUS study followed patients for three years. While bleeding rates were higher in those taking Brilinta and aspirin compared to aspirin alone, the rates of fatal bleeding, intracranial hemorrhage, and death from any cause were no different.